Cargando…
An Inverse Dose Optimization Algorithm for Three-Dimensional Brachytherapy
PURPOSE: To investigate an implementation method and the results of an inverse dose optimization algorithm, Gradient Based Planning Optimization (GBPO), for three-dimensional brachytherapy. METHODS: The GBPO used a quadratic objective function, and a dwell time modulation item was added to the objec...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7606999/ https://www.ncbi.nlm.nih.gov/pubmed/33194640 http://dx.doi.org/10.3389/fonc.2020.564580 |
_version_ | 1783604552646262784 |
---|---|
author | Wang, Xianliang Wang, Pei Tang, Bin Kang, Shengwei Hou, Qing Wu, Zhangwen Gou, Chengjun Li, Lintao Orlandini, Lucia Lang, Jinyi Li, Jie |
author_facet | Wang, Xianliang Wang, Pei Tang, Bin Kang, Shengwei Hou, Qing Wu, Zhangwen Gou, Chengjun Li, Lintao Orlandini, Lucia Lang, Jinyi Li, Jie |
author_sort | Wang, Xianliang |
collection | PubMed |
description | PURPOSE: To investigate an implementation method and the results of an inverse dose optimization algorithm, Gradient Based Planning Optimization (GBPO), for three-dimensional brachytherapy. METHODS: The GBPO used a quadratic objective function, and a dwell time modulation item was added to the objective function to restrict the dwell time variance. We retrospectively studied 4 cervical cancer patients using different applicators and 15 cervical cancer patients using the Fletcher applicator. We assessed the plan quality of GBPO by isodose lines for the patients using different applicators. For the 15 patients using the Fletcher applicator, we utilized dose-volume histogram (DVH) parameters of HR-CTV (D(100%), V(150%)) and organs at risk (OARs) (D(0.1cc), D(1cc), D(2cc)) to evaluate the difference between the GBPO plans and the IPSA (Inverse Planning Simulated Annealing) plans, as well as the GBPO plans and the Graphic plans. RESULTS: For the 4 patients using different applicators, the dose distributions are conformable. For the 15 patients using the Fletcher applicator, when the dwell time modulation factor (DTMF) is less than 20, the dwell time deviation reduces quickly; however, after the DTMF increased to 100, the dwell time deviation has no remarkable change. The difference in dosimetric parameters between the GBPO plans and the IPSA plans is not statistically significant (P>0.05). The GBPO plans have a higher D(100%) (3.57 ± 0.36, 3.38 ± 0.34; P<0.01) and a lower V(150%) (55.73 ± 4.06, 57.75 ± 3.79; P<0.01) than those of the Graphic plans. The differences in other DVH parameters are negligible between the GBPO plans and the Graphic plans. CONCLUSIONS: The GBPO plans have a comparable quality as the IPSA plans and the Graphic plans for the studied cervical cancer cases. The GBPO algorithm could be integrated into a three-dimensional brachytherapy treatment planning system after studying more sites. |
format | Online Article Text |
id | pubmed-7606999 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-76069992020-11-13 An Inverse Dose Optimization Algorithm for Three-Dimensional Brachytherapy Wang, Xianliang Wang, Pei Tang, Bin Kang, Shengwei Hou, Qing Wu, Zhangwen Gou, Chengjun Li, Lintao Orlandini, Lucia Lang, Jinyi Li, Jie Front Oncol Oncology PURPOSE: To investigate an implementation method and the results of an inverse dose optimization algorithm, Gradient Based Planning Optimization (GBPO), for three-dimensional brachytherapy. METHODS: The GBPO used a quadratic objective function, and a dwell time modulation item was added to the objective function to restrict the dwell time variance. We retrospectively studied 4 cervical cancer patients using different applicators and 15 cervical cancer patients using the Fletcher applicator. We assessed the plan quality of GBPO by isodose lines for the patients using different applicators. For the 15 patients using the Fletcher applicator, we utilized dose-volume histogram (DVH) parameters of HR-CTV (D(100%), V(150%)) and organs at risk (OARs) (D(0.1cc), D(1cc), D(2cc)) to evaluate the difference between the GBPO plans and the IPSA (Inverse Planning Simulated Annealing) plans, as well as the GBPO plans and the Graphic plans. RESULTS: For the 4 patients using different applicators, the dose distributions are conformable. For the 15 patients using the Fletcher applicator, when the dwell time modulation factor (DTMF) is less than 20, the dwell time deviation reduces quickly; however, after the DTMF increased to 100, the dwell time deviation has no remarkable change. The difference in dosimetric parameters between the GBPO plans and the IPSA plans is not statistically significant (P>0.05). The GBPO plans have a higher D(100%) (3.57 ± 0.36, 3.38 ± 0.34; P<0.01) and a lower V(150%) (55.73 ± 4.06, 57.75 ± 3.79; P<0.01) than those of the Graphic plans. The differences in other DVH parameters are negligible between the GBPO plans and the Graphic plans. CONCLUSIONS: The GBPO plans have a comparable quality as the IPSA plans and the Graphic plans for the studied cervical cancer cases. The GBPO algorithm could be integrated into a three-dimensional brachytherapy treatment planning system after studying more sites. Frontiers Media S.A. 2020-10-20 /pmc/articles/PMC7606999/ /pubmed/33194640 http://dx.doi.org/10.3389/fonc.2020.564580 Text en Copyright © 2020 Wang, Wang, Tang, Kang, Hou, Wu, Gou, Li, Orlandini, Lang and Li http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Wang, Xianliang Wang, Pei Tang, Bin Kang, Shengwei Hou, Qing Wu, Zhangwen Gou, Chengjun Li, Lintao Orlandini, Lucia Lang, Jinyi Li, Jie An Inverse Dose Optimization Algorithm for Three-Dimensional Brachytherapy |
title | An Inverse Dose Optimization Algorithm for Three-Dimensional Brachytherapy |
title_full | An Inverse Dose Optimization Algorithm for Three-Dimensional Brachytherapy |
title_fullStr | An Inverse Dose Optimization Algorithm for Three-Dimensional Brachytherapy |
title_full_unstemmed | An Inverse Dose Optimization Algorithm for Three-Dimensional Brachytherapy |
title_short | An Inverse Dose Optimization Algorithm for Three-Dimensional Brachytherapy |
title_sort | inverse dose optimization algorithm for three-dimensional brachytherapy |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7606999/ https://www.ncbi.nlm.nih.gov/pubmed/33194640 http://dx.doi.org/10.3389/fonc.2020.564580 |
work_keys_str_mv | AT wangxianliang aninversedoseoptimizationalgorithmforthreedimensionalbrachytherapy AT wangpei aninversedoseoptimizationalgorithmforthreedimensionalbrachytherapy AT tangbin aninversedoseoptimizationalgorithmforthreedimensionalbrachytherapy AT kangshengwei aninversedoseoptimizationalgorithmforthreedimensionalbrachytherapy AT houqing aninversedoseoptimizationalgorithmforthreedimensionalbrachytherapy AT wuzhangwen aninversedoseoptimizationalgorithmforthreedimensionalbrachytherapy AT gouchengjun aninversedoseoptimizationalgorithmforthreedimensionalbrachytherapy AT lilintao aninversedoseoptimizationalgorithmforthreedimensionalbrachytherapy AT orlandinilucia aninversedoseoptimizationalgorithmforthreedimensionalbrachytherapy AT langjinyi aninversedoseoptimizationalgorithmforthreedimensionalbrachytherapy AT lijie aninversedoseoptimizationalgorithmforthreedimensionalbrachytherapy AT wangxianliang inversedoseoptimizationalgorithmforthreedimensionalbrachytherapy AT wangpei inversedoseoptimizationalgorithmforthreedimensionalbrachytherapy AT tangbin inversedoseoptimizationalgorithmforthreedimensionalbrachytherapy AT kangshengwei inversedoseoptimizationalgorithmforthreedimensionalbrachytherapy AT houqing inversedoseoptimizationalgorithmforthreedimensionalbrachytherapy AT wuzhangwen inversedoseoptimizationalgorithmforthreedimensionalbrachytherapy AT gouchengjun inversedoseoptimizationalgorithmforthreedimensionalbrachytherapy AT lilintao inversedoseoptimizationalgorithmforthreedimensionalbrachytherapy AT orlandinilucia inversedoseoptimizationalgorithmforthreedimensionalbrachytherapy AT langjinyi inversedoseoptimizationalgorithmforthreedimensionalbrachytherapy AT lijie inversedoseoptimizationalgorithmforthreedimensionalbrachytherapy |